Skip to main content
Equibles
TECX logo

TECX · Tectonic Therapeutic, Inc. · Metrics

Track TECX — free

Use TECX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TECX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.60 -1.24 (-5.68%)
Russell 2000 member Rebalance outlook locked
Market Cap
$430.67M
Shares
19.55M
Volume · Oct 22 251.39K Avg daily vol (3M) 215.21K

TECX metrics

71 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$21.84
Market cap
$430.67M

Price action

20 metrics
Price change (1W)
+4.2%
Price change (30D)
-17.6%
Price change (3M)
-30.9%
Price change (6M)
-23.4%
Price change (YTD)
+4.7%
Price change (1Y)
+15.0%
Trailing year
Price change (5Y)
—
52-week high
$37.93
52-week low
$16.44
Change from 52-week high
-42.4%
Change from 52-week low
+32.8%
Annualized volatility
73.8%
Annualized volatility (3M)
65.7%
Beta
0.9
RSI (14D)
36.6
Price vs SMA 50
-22.4%
Price vs SMA 200
-22.3%
Avg volume (3M)
215,205
Relative volume
0.7
Average dollar volume
$6.14M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
19.55M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.9
reciprocal yield 52.0%
FCF yield
-16.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-19.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
8.1×
reciprocal yield 12.3%
EV / EBIT historical average (5Y)
8.1×
reciprocal yield 12.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-02-24

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$94.92M
Net income (TTM)
−$85.79M
Trailing 12 months
Diluted EPS (TTM)
$-4.57
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-5.05
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-4.56
Operating cash flow per diluted share (TTM)
$-3.84
Free cash flow per diluted share (TTM)
$-3.85
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$3.84
Stock compensation per diluted share (TTM)
$0.69
Book value per share
$13.41

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.5%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-38.3%
Return on assets
-36.2%
Debt / equity
0.0
Current ratio
22.3
EBITDA (TTM)
—
Free cash flow (TTM)
−$72.42M
Quick ratio
22.3
Interest coverage
-2,373.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$226.88M
Latest balance sheet
Cash & equivalents
$227.07M
Total assets
$237.03M
Total debt
$186,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$72.14M
Capital expenditures (TTM)
$279,000
R&D (TTM)
$72.19M
SG&A (TTM)
—
Stock compensation (TTM)
$13.02M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
124
13F filer change QoQ
+11
Institutional ownership
72.5%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
30.5%
Private-fund adviser ownership
27.8%
Active holders' share change QoQ
+0.7%
Holder tenure
5.5
Price vs estimated holder cost
+47.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.2%

Short interest

3 metrics
Short interest
11.4%
Latest settlement · 8.1 days to cover
Days to cover
8.1d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$15,425
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1681087 CUSIP 878972108 13F (30d) 8 filings 8 filers Visit website Investor relations